TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993 May 29, 1987
